Corvus Pharmaceuticals (CRVS) Set to Announce Earnings on Tuesday

Corvus Pharmaceuticals (NASDAQ:CRVS – Get Free Report) is set to release its earnings data after the market closes on Tuesday, November 7th. Analysts expect Corvus Pharmaceuticals to post earnings of ($0.16) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link. Corvus Pharmaceuticals […]

Related Keywords

,Hedge Funds Weigh In On Corvus Pharmaceuticals ,Renaissance Technologies ,Corvus Pharmaceuticals Inc ,Corvus Pharmaceuticals Price Performance ,Earnings History For Corvus Pharmaceuticals ,Vanguard Group Inc ,Cantor Fitzgerald ,Corvus Pharmaceuticals Company Profile ,Corvus Pharmaceuticals ,News Ratings For Corvus Pharmaceuticals Daily ,Blackrock Inc ,Get Free Report ,Sigma Advisers ,Two Sigma Investments ,Sigma Investments ,Corvus Pharmaceuticals Daily ,Nasdaq Crvs ,Ccrvs ,Medical ,Earnings ,